3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole
C23H25N7O — CID 118326938
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole
3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole (PubChem CID 118326938) has the molecular formula C23H25N7O and a molecular weight of 415.50 g/mol. Its IUPAC name is 3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole.
Molecular Properties
| Compound Name | 3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole |
|---|---|
| PubChem CID | 118326938 |
| Molecular Formula | C23H25N7O |
| Molecular Weight | 415.50 g/mol |
| Exact Mass | 415.21 |
| IUPAC Name | 3-(4-methylphenyl)-5-[1-methyl-2-[(2-piperazin-1-yl-4-pyridinyl)methyl]imidazol-4-yl]-1,2,4-oxadiazole |
| SMILES | Cc1ccc(-c2noc(-c3cn(C)c(Cc4ccnc(N5CCNCC5)c4)n3)n2)cc1 |
| InChI | InChI=1S/C23H25N7O/c1-16-3-5-18(6-4-16)22-27-23(31-28-22)19-15-29(2)21(26-19)14-17-7-8-25-20(13-17)30-11-9-24-10-12-30/h3-8,13,15,24H,9-12,14H2,1-2H3 |
| InChIKey | CBLFNSCOECXZOM-UHFFFAOYSA-N |
| XLogP | 2.84 |
| TPSA | 84.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 415.50 |
| LogP ≤ 5 | 2.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118326938 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.